Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$24.33 – $32.21
54% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | $2.11B | $1.63B | $2.19B | $2.57B | $2.52B | $2.66B | $2.60B |
| Cost of revenue | $1.21B | $1.18B | $879.2M | $1.69B | $2.16B | $2.60B | $2.16B | $2.29B |
| Gross profit | $970.8M | $922.6M | $753.4M | $501.9M | $403.1M | −$76.5M | $508.1M | $312.6M |
| Gross margin | 44.6% | 43.8% | 46.1% | 22.9% | 15.7% | -3.0% | 19.1% | 12.0% |
| R&D | $27.6M | $24.6M | $20.2M | $24.0M | $29.2M | $69.2M | $29.2M | $27.6M |
| Operating income | $211.4M | $163.5M | $57.1M | $228.1M | $34.2M | −$476.4M | $88.5M | −$40.2M |
| EBITDA | $355.2M | $330.4M | $209.4M | $364.8M | $250.7M | −$158.4M | $427.2M | $274.9M |
| Net income | $149.0M | $122.8M | $6.3M | $110.3M | −$44.3M | −$620.7M | −$127.9M | −$172.0M |
| Net margin | 6.8% | 5.8% | 0.4% | 5.0% | -1.7% | -24.6% | -4.8% | -6.6% |
| EPS (diluted) | 4.91 | 4.05 | 0.21 | 3.64 | -1.46 | -20.02 | -4.06 | -5.45 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.7B | $-1.10 | $-1.14–$-1.09 | 1 |
| 2027 | $2.7B | $-0.63 | $-0.65–$-0.62 | 1 |
| 2028 | $2.7B | $0.03 | $0.03–$0.03 | 1 |
| 2029 | $2.8B | $-0.51 | $-0.52–$-0.50 | 1 |
Forward consensus · source: Financial Modeling Prep
LENZING AG ORD
No one on the platform currently holds LNZNF.
No tracked institution reports a position in LNZNF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2010-12-28 | 7-for-1 |
No one on the platform has traded LNZNF yet.
| $18.9B |
| — |
| MXCHYOrbia Advance Corporation, S.A.B. de C.V. | $2.55 | -1.16% | $1.3B | — |
| OCINFOCI N.V. | $4.45 | +0.00% | $939M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.4× sales vs its 0.6× historical median P/S.
Fair value ≈ $40.11 · price $28.61 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.